Evidence map›Paper›PMID 32507538›Full record

Trial reportJournal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners

Vitamin D Supplementation Improves Health-Related Quality of Life and Physical Performance in Children with Sickle Cell Disease and in Healthy Children.

Kelly A Dougherty, Joan I Schall, Chiara Bertolaso, Kim Smith-Whitley, Virginia A Stallings

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04662476 (Effect of Vitamin D Supplementation on Sickle Cell Disease Hospitalisation and Related Complications Among Children in Mulago Hospital), which is not on this map. Cited by 14 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 4 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04662476 naunknown statusnot on this map

Effect of Vitamin D Supplementation on Sickle Cell Disease Hospitalisation and Related Complications Among Children in Mulago Hospital: A Randomised Clinical Trial

TypeinterventionalSponsorMakerere UniversityRan2021 to 2022Enrolled662ConditionsChildren With Sickle Cell Disease at Mulago HospitalArmsVitamin D3
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 4 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Safety and efficacy of monthly high-dose vitamin DEuropean journal of pediatrics · 2024
    Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Vitamin D level in relation to depression symptoms during adolescence.Child and adolescent psychiatry and mental health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kelly A Dougherty
Joan I Schall
Chiara Bertolaso
Kim Smith-Whitley
Virginia A Stallings

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Institutional Clinical and Translational Science AwardKL2RR024132 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$5.1M
VitaminA and Sickle Cell Disease:Improving Suboptimal Status with SupplementationK23HL114637 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI DOUGHERTY, KELLY ANN · 2013 to 2014
$168k
NCATS NIH HHS UL1 TR000003NCRR NIH HHS KL2 RR024132NCRR NIH HHS UL1 RR024134NHLBI NIH HHS K23 HL114637
6 · The paper itself

Abstract

introductionNo study determined if vitamin D supplementation improves health-related quality of life (HRQL) using pediatric Patient-Reported Outcomes Measurement Information System or physical functioning in type SS sickle cell disease (HbSS).

methodSubjects with HbSS (n = 21) and healthy subjects (n = 23) were randomized to daily oral doses (4,000 vs. 7,000 IU) of cholecalciferol (vitamin D

resultsIn subjects with HbSS, significant reductions in pain, fatigue, and depressive symptoms and improved upper-extremity function were observed. In healthy subjects, significant reductions in fatigue and improved upper-extremity function were observed. Significant improvements in peak power and dorsiflexion isometric maximal voluntary contraction torques were observed in both groups. In subjects with HbSS, improved plantar flexion isometric maximal voluntary contraction torques were observed. Both groups saw significant improvement in their total Bruininks-Oseretsky Test of Motor Proficiency score. DISCUSSION: Daily high-dose vitamin D supplementation for African American children with and without HbSS improved HRQL and physical performance.

Indexed as

Anemia, Sickle CellDietary SupplementsPhysical Functional PerformanceQuality of LifeVitamin DVitamin D DeficiencyAdolescentChildFemaleHumansMaleVitamin Dmuscle strengthphysical performancequality of lifeSickle cell diseasevitamin D supplementation

Identifiers

PMID32507538
PMCPMC7483775
OpenAlexW3033286463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.